KKR buys majority stake in health software company Therapy Brands
Global investment firm KKR plans to acquire a majority stake in health software company Therapy Brands. PSG, a previous investor in the company, will remain a minority shareholder.
Global investment firm KKR plans to acquire a majority stake in health software company Therapy Brands. PSG, a previous investor in the company, will remain a minority shareholder.
Healthcare consumers are increasingly aware of specific therapies in development or on the market that can help treat the diseases they or their loved ones may be suffering from — and this growing awareness is changing the precision medicine arena.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The company sources product candidates from academic and commercial research and then launches subsidiary companies to develop them.
San Francisco-based Clarify Health's new funding round led by private equity firm KKR will help the company build out data science expertise, buy data assets and enter the life sciences sector.
WebMD's acquisition calls to mind just how much the business of online searches for health information has evolved.
Nasal obstruction is a significant problem that effects more than three million Americans each year. Spirox is developing a minimally invasive device that would decrease the need for surgery.